326 related articles for article (PubMed ID: 26166460)
1. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
[TBL] [Abstract][Full Text] [Related]
2. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
3. Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model.
Jun HY; Park SH; Kim HS; Yoon KH
Acad Radiol; 2010 Jan; 17(1):54-60. PubMed ID: 19815430
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
6. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
[TBL] [Abstract][Full Text] [Related]
7. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.
Willmann JK; Kimura RH; Deshpande N; Lutz AM; Cochran JR; Gambhir SS
J Nucl Med; 2010 Mar; 51(3):433-40. PubMed ID: 20150258
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble.
Zhang H; Tam S; Ingham ES; Mahakian LM; Lai CY; Tumbale SK; Teesalu T; Hubbard NE; Borowsky AD; Ferrara KW
Biomaterials; 2015 Jul; 56():104-13. PubMed ID: 25934284
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.
Weller GE; Wong MK; Modzelewski RA; Lu E; Klibanov AL; Wagner WR; Villanueva FS
Cancer Res; 2005 Jan; 65(2):533-9. PubMed ID: 15695396
[TBL] [Abstract][Full Text] [Related]
10. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
[TBL] [Abstract][Full Text] [Related]
11. Molecular Ultrasound Imaging of αvβ3-Integrin Expression in Carotid Arteries of Pigs After Vessel Injury.
Rix A; Fokong S; Heringer S; Pjontek R; Kabelitz L; Theek B; Brockmann MA; Wiesmann M; Kiessling F
Invest Radiol; 2016 Dec; 51(12):767-775. PubMed ID: 27119438
[TBL] [Abstract][Full Text] [Related]
12. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.
Ellegala DB; Leong-Poi H; Carpenter JE; Klibanov AL; Kaul S; Shaffrey ME; Sklenar J; Lindner JR
Circulation; 2003 Jul; 108(3):336-41. PubMed ID: 12835208
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound Molecular Imaging of Neovascularization for Evaluation of Endometrial Receptivity Using Magnetic iRGD-Modified Lipid-Polymer Hybrid Microbubbles.
He Y; Zhou M; Li S; Gong Z; Yan F; Liu H
Int J Nanomedicine; 2022; 17():5869-5881. PubMed ID: 36483520
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles.
Zhang H; Ingham ES; Gagnon MK; Mahakian LM; Liu J; Foiret JL; Willmann JK; Ferrara KW
Biomaterials; 2017 Feb; 118():63-73. PubMed ID: 27940383
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
[TBL] [Abstract][Full Text] [Related]
16. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
[TBL] [Abstract][Full Text] [Related]
17. Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles.
Spivak I; Rix A; Schmitz G; Fokong S; Iranzo O; Lederle W; Kiessling F
Mol Imaging Biol; 2016 Apr; 18(2):180-90. PubMed ID: 26391990
[TBL] [Abstract][Full Text] [Related]
18. Quantification of bound microbubbles in ultrasound molecular imaging.
Daeichin V; Akkus Z; Skachkov I; Kooiman K; Needles A; Sluimer J; Janssen B; Daemen MJ; van der Steen AF; de Jong N; Bosch JG
IEEE Trans Ultrason Ferroelectr Freq Control; 2015 Jun; 62(6):1190-200. PubMed ID: 26067053
[TBL] [Abstract][Full Text] [Related]
19. Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice.
Wang X; Hagemeyer CE; Hohmann JD; Leitner E; Armstrong PC; Jia F; Olschewski M; Needles A; Peter K; Ahrens I
Circulation; 2012 Jun; 125(25):3117-26. PubMed ID: 22647975
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of tumor angiogenesis using microbubbles conjugated with RGD peptides and contrast enhanced ultrasound].
Hu GQ; Yang L; Xiao YB; Xie JJ; Wu JF; Cai JJ; Liu J; Liao WJ; Bin JP
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):655-8. PubMed ID: 21122377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
